MRVL vs PCVX · P/E 100, rev $5.16B vs $6.84B cap
Marvell Technology Group Ltd (MRVL) versus Vaxcyte Inc (PCVX) — a side-by-side from cached financials, not a winner call.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ.
Vaxcyte Inc (PCVX) is a biotechnology company listed on US.
Latest reported MRVL revenue for 2026-08-01 was $5.16B. Net income was $342.5M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
PCVX does not have a complete income-statement cache yet.
MRVL currently screens at market cap $253.51B and trailing P/E 99.8. PCVX currently screens at market cap $6.84B.
Not investment advice. Open the MRVL and PCVX stock pages for the full models.
Not investment advice.